These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37286365)

  • 1. Structural basis for the mechanism of interaction of SARS-CoV-2 B.1.640.2 variant RBD with the host receptors hACE2 and GRP78.
    Shafiq A; Khalid U; Abdur Rehman U; Abdullah Almuqri E; Muddassir M; Ahmad S; Khan MI; Khan A; Wei DQ
    J Biomol Struct Dyn; 2024; 42(4):2034-2042. PubMed ID: 37286365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the binding and dynamic features of A.30 variant revealed higher binding of RBD for hACE2 and escapes the neutralizing antibody: A molecular simulation approach.
    Shafiq A; Zubair F; Ambreen A; Suleman M; Yousafi Q; Rasul Niazi Z; Anwar Z; Khan A; Mohammad A; Wei DQ
    Comput Biol Med; 2022 Jul; 146():105574. PubMed ID: 35533461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights into the binding interactions and energetics of the omicron spike variant with hACE2 and a neutralizing antibody.
    Kumar V; Shefrin S; Sundar D
    J Struct Biol; 2024 Jun; 216(2):108087. PubMed ID: 38494148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection:
    AlGhamdi NA; Alsuwat HS; Borgio JF; AbdulAzeez S
    J Biomol Struct Dyn; 2022 Apr; 40(6):2635-2646. PubMed ID: 33138699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.
    Kumar R; Murugan NA; Srivastava V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data.
    Khan A; Waris H; Rafique M; Suleman M; Mohammad A; Ali SS; Khan T; Waheed Y; Liao C; Wei DQ
    Int J Biol Macromol; 2022 Mar; 200():438-448. PubMed ID: 35063482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural communication fingerprinting and dynamic investigation of RBD-hACE2 complex from BA.1 × AY.4 recombinant variant (Deltacron) of SARS-CoV-2 to decipher the structural basis for enhanced transmission.
    Wang J; Fatima Muhammad S; Aman S; Khan A; Munir S; Khan M; Mohammad A; Waheed Y; Munir M; Guo L; Chen L; Wei DQ
    J Biomol Struct Dyn; 2023; 41(16):7665-7676. PubMed ID: 36129018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations.
    Wu J; Zhang HX; Zhang J
    Phys Chem Chem Phys; 2023 Jan; 25(3):2304-2319. PubMed ID: 36597957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness
    Zhang Z; Zhang J; Wang J
    Front Public Health; 2022; 10():952916. PubMed ID: 36091499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2.
    Celik I; Khan A; Dwivany FM; Fatimawali ; Wei DQ; Tallei TE
    Mol Divers; 2022 Dec; 26(6):3309-3324. PubMed ID: 35138508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2.
    Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT
    J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity.
    Hanifa M; Salman M; Fatima M; Mukhtar N; Almajhdi FN; Zaman N; Suleman M; Ali SS; Waheed Y; Khan A
    Front Cell Dev Biol; 2022; 10():940863. PubMed ID: 36733340
    [No Abstract]   [Full Text] [Related]  

  • 13. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity.
    Kumar V; Singh J; Hasnain SE; Sundar D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies.
    Wang WB; Liang Y; Jin YQ; Zhang J; Su JG; Li QM
    J Mol Graph Model; 2021 Dec; 109():108035. PubMed ID: 34562851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.
    Fernandez RA; Quimque MT; Notarte KI; Manzano JA; Pilapil DY; de Leon VN; San Jose JJ; Villalobos O; Muralidharan NH; Gromiha MM; Brogi S; Macabeo APG
    J Biomol Struct Dyn; 2022; 40(22):12209-12220. PubMed ID: 34463219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most frequently harboured missense variants of hACE2 across different populations exhibit varying patterns of binding interaction with spike glycoproteins of emerging SARS-CoV-2 of different lineages.
    Tahsin A; Ahmed R; Bhattacharjee P; Adiba M; Al Saba A; Yasmin T; Chakraborty S; Hasan AKMM; Nabi AHMN
    Comput Biol Med; 2022 Sep; 148():105903. PubMed ID: 35932731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
    Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach.
    Hakami AR
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.